• YottaMark

  Led · Series D · Aug 2012

  YottaMark is a Redwood City, CA-based provider of a fresh food traceability and insights platform called HarvestMark. HarvestMark provides analytics and visibility that enable food suppliers to optimize the supply chain and connect directly with shoppers to build brand trust and loyalty. Its solutions are used by 300 brands sourcing fresh food from 4,000 farms across Canada to Argentina. Customers include The Kroger Co., Driscoll's Strawberry Associates, Sun World and Calavo. The company intends to use the $24M Series D capital to accelerate its sales and marketing efforts. YottaMark is led by CEO J. Scott Carr and sells HarvestMark solutions to large produce companies and retailers. YottaMark has developed a low-cost tracking system that uses printable 12-digit codes on labels or packaging to trace produce from farm to grocery store. Consumers can visit a website, send a text message, or submit a photo of the label to receive information on where produce was grown, when it shipped, and points along its journey. The company positions this transparency as reassurance for retailers and consumers and as a marketing claim for produce brands. Because the system relies on printable codes rather than RFID, YottaMark says the technology can be deployed on every unit sold. The company is also targeting electronics manufacturers concerned about counterfeits, though it has not yet announced customers in that space. YottaMark raised financing to expand sales and marketing efforts.

• INVIDI Technologies

  Participated · Series D · May 2010

  Invidi develops software applications and a digital set-top box application that deliver targeted advertising and personalized marketing messages to individual TV viewers. Its technology enables the sales of digital products and services such as VOD, PVR, pay-per-view events, internet, voice, wireless services, and triple-play offers. The company has distribution agreements with Dish Network and DirecTV and its technology was trialed in Comcast’s Baltimore system, where addressable ads proved 65% more efficient and 32% more effective. Founded in 2000, Invidi recently secured over $23 million in Series D financing led by Google. As part of the funding, Shishir Mehrotra of Google TV Ads and YouTube Ads joined Invidi’s board, and Google committed to collaborating on TV-ad products with potential integration into Android-based TV software. The round should support expansion of Invidi’s addressable TV-ad offerings and commercial partnerships. Invidi builds technology to target advertisements to individual TV set-top boxes. Its platform targets ads based on age, gender, location, income and ethnicity by analyzing remote-control usage, ratings, program-guide information and census data. The company is based in Princeton, NJ. Earlier capital came from EnerTech Capital, InterWest Partners and Menlo Ventures. Those earlier investors returned to participate in a new $25 million investment led by WPP. No revenue or user metrics were disclosed in the articles.

• OmniGuide

  Participated · Equity · May 2008

  OmniGuide Surgical develops and manufactures the BeamPath® Laser System, a flexible fiber-enabled CO2 laser platform for minimally invasive surgery. The company designs and manufactures its system in Cambridge, Massachusetts using proprietary technology invented at MIT. The BeamPath system has been used in nearly 100,000 surgical procedures, primarily in Gynecology and ENT. OmniGuide positions CO2 laser energy as causing less tissue damage versus other advanced energy products, which it says can improve surgeon experience and patient outcomes. The company distributes the BeamPath Laser System in the U.S. through a direct sales force. OmniGuide recently closed a $15 million equity financing to support commercialization and product launches into the ENT market and further growth in Gynecology. OmniGuide is a Cambridge, Massachusetts-based medical device company specializing in advanced energy surgical products for the operating room. Its core product is the BeamPath® flexible laser system, which has been used in over 40,000 adult and pediatric surgical procedures across gynecology, ENT and neurosurgery. The company’s fiber products are based on proprietary technology invented at MIT and originally published in Science and Nature. OmniGuide distributes in the U.S. through a direct sales force and in Europe through distribution partners. Led by President and CEO Scott Flora, the company intends to use the proceeds of the recent financing to accelerate commercialization of its advanced energy surgical products. The company closed a $35M financing with an affiliate of OrbiMed Advisors. OmniGuide produces BeamPath, a flexible optical fiber used to guide CO2 laser beams in surgery. The company said it will use the new funding to expand its laser surgery business. BeamPath has been used in more than 3,000 surgeries, including procedures for head and neck cancers, airway clearing, and hearing restoration. More than 200 hospitals in the U.S. and Europe use the system. OmniGuide reported $2 million in revenue last year and CEO Yoel Fink told VentureWire he expects the company to be profitable in 2009. The company has about 80 employees and originally licensed the technology from MIT. OmniGuide is based in Cambridge, Mass.

No current team members are available.